Form D · Biotechnology
ORAGENICS INC
Tampa, FL · CIK 0001174940
Offering snapshot reported Aug 8, 2023 · SEC filing
- Reported sold
- $850K Offering amount: $850K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Aug 4, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 8, 2023 | Initial | $850,000 | No comparison | 2 | SEC filing |
| May 6, 2020 | Initial | $4,600,000 | No comparison | 1 | SEC filing |
| Apr 12, 2018 | Initial | $1,800,000 | No comparison | 2 | SEC filing |
| Nov 14, 2017 | Initial | $6,676,209 | No comparison | 5 | SEC filing |
| May 19, 2017 | Initial | $1,302,292 | No comparison | 3 | SEC filing |
| Jul 13, 2016 | Initial | $4,666,666 | No comparison | 3 | SEC filing |
| Oct 15, 2013 | Initial | $9,900,000 | No comparison | 1 | SEC filing |
| Aug 10, 2012 | Initial | $13,000,000 | No comparison | 53 | SEC filing |
| Aug 10, 2012 | Initial | $2,538,185 | No comparison | 1 | SEC filing |
| Jun 15, 2012 | Initial | $5,798,001 | No comparison | 1 | SEC filing |
| Apr 5, 2012 | Initial | $11,237,011 | No comparison | 1 | SEC filing |
| Aug 11, 2010 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Jan 13, 2010 | Initial | $3,000,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-489018
Source: Form D, filed Aug 8, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Bohunicky | Executive |
| John Bonfiglio | Director, Executive |
| Alan Dunton | Director |
| Jeffrey Hillman | Director, Executive |
| David Brian Hirsch | Director, Executive |
| Janet Huffman | Executive |
| Alan Joslyn | Director, Executive |
| Robert Koski | Director |
| Christine Koski | Director |
| Kimberly Murphy | Director, Executive |
| Charles Pope | Director |
| Michael Sullivan | Executive |
| Frederick Telling | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4902 Eisenhower Boulevard, Suite 125
Tampa, FL, 33634
Tampa, FL, 33634